Vaccines
15 November 2016
Transgene Presents Preclinical Results of TG1050, an HBV-targeted Immunotherapy, at AASLD 2016 Liver Meeting14 November 2016
CEL-SCI Reports Preclinical Data Showing LEAPS Vaccine is Successful in Treating Rheumatoid Arthritis14 November 2016
Aduro Biotech Highlights Positive Clinical Results from Second Cohort of Phase 1b Mesothelioma Clinical Trial10 November 2016
Inovio Pharmaceuticals Zika Vaccine Protects Animals from Infection, Brain Damage and Death8 November 2016
DBV Technologies Completes Enrollment of Phase II Study of Viaskin Milk for the Treatment of Milk Allergic Patients7 November 2016
CryoVax(R) : Next Generation Immunotherapy for Metastatic Colorectal Cancer Begins USA Phase IIb Clinical Trial7 November 2016
Neovacs enrolls the first U.S. Patient in Phase IIb study of IFNa Kinoid for treatment of Systemic Lupus Erythematosus (SLE)7 November 2016
Mucosis Initiates First-in-Human Study of SynGEM®, a Needle-Free Nasal Spray RSV Vaccine4 November 2016
ARTES and BioSun Announce Co-Development for HPV Vaccine28 October 2016
Opiant Pharmaceuticals, Inc. Licenses Heroin Vaccine From Walter Reed Army Institute of Research and National Institute on Drug Abuse28 October 2016
Data from Phase 1 Trial of Triplex Vaccine for Control of Cytomegalovirus Published in Blood25 October 2016
Topline Results from Two-Year Follow-Up Study of Viaskin Peanut Show Long-Lasting and High Levels of Desensitization to Peanut25 October 2016
GSK announces US regulatory submission of candidate vaccine for prevention of shingles24 October 2016
Inovio Announces FDA Request for Additional Information For Phase III Program; Trial Initiation Delayed20 October 2016
Pfizer Awarded Grant to Evaluate Vaccine to Protect Newborns Against Group B Streptococcus Infection19 October 2016
Canadian Ebola vaccine enters new trial phase17 October 2016
First Patient Randomized in Multiple Dose Cohort of Phase 1/1b Trial with Transgene’s TG1050 in Chronic Hepatitis B Patients13 October 2016
Immunovaccine Announces Positive Phase 1 Topline Data for DepoVax(TM)-based Respiratory Syncytial Virus Vaccine Candidate11 October 2016
Positive Preclinical Data for Immunovaccine’s DepoVax(TM)-based Malarial Vaccine Presented at 2016 World Vaccine Congress EuropeNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
Subscribe
Newsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
Subscribe
Featured reports